Results 21 to 30 of about 2,547 (172)
Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits. [PDF]
The introduction of drug-eluting stents (DES) has dramatically reduced restenosis rates compared with bare metal stents, but in-stent thrombosis remains a safety concern, necessitating prolonged dual anti-platelet therapy. The drug 6-Mercaptopurine (6-MP)
Matthijs S Ruiter +9 more
doaj +1 more source
Very late stent thrombosis is a rare but devastating complication after percutaneous coronary revascularization. Pathological studies have demonstrated that neoatherosclerosis plays a major role in certain patients with very late stent thrombosis ...
Teresa Bastante +6 more
doaj +1 more source
Introduction: Bioresorbable stent has the theoretical advantage in the pediatric age group; however, experience in the literature is very limited.
Marhisham Che Mood +6 more
doaj +1 more source
Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent [PDF]
Bioresorbable stents are an emerging technology in the endovascular treatment of femoropopliteal lesions. They address the issue of leaving permanent stents in the treated arterial segment that are only temporarily needed to treat dissection or recoil.
Bontinck, Jan +5 more
openaire +3 more sources
BIORESORBABLE VASCULAR SCAFFOLDS (SYSTEMATIC LITERATURE REVIEW)
Introduction: Modern interventional surgery is one of the most dynamically developing areas of modern medicine. Evidence of this is the bioresorbable stent appearance in its stockpile – intravascular frames, which provide temporary mechanical support and
Vladimir Plechev +5 more
doaj +1 more source
Purpose: Neurovascular injuries and hand ischemia can occur in up to 20% of cases of supracondylar fractures of the humerus (SCH) in children, and their management is still controversial. Case report: We report a case of a brachial artery acute occlusion
Francesca Tomei +7 more
doaj +1 more source
Coronary artery aneurysm (CAA) formation is a rare complication of coronary intervention that may develop after implantation of bare-metal or drug-eluting stents.
Marcos García-Guimaraes +6 more
doaj +1 more source
Bioresorbable Vascular Scaffolds in In-Stent Restenosis
We read with great interest the study of Alfonso et al. [(1)][1] assessing the value of bioresorbable vascular scaffold (BVS) for in-stent restenosis (ISR) treatment. The authors prospectively included patients treated with BVS for both bare-metal and drug-eluting stent (DES) ISR.
Moscarella E., Ielasi A., Varricchio A.
openaire +2 more sources
Background / objectivesAutomatic algorithms for stent struts segmentation in optical coherence tomography (OCT) images of coronary arteries have been developed over the years, particularly with application on metallic stents.
Marco Bologna +7 more
doaj +1 more source
Bioresorbable polymeric stents have attracted great interest for coronary artery disease because they can provide mechanical support first and then disappear within a desired time period.
Tianyang Qiu +4 more
doaj +1 more source

